Renaissance Technologies - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 91 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$348,000
-93.1%
142,012
-88.5%
0.00%
-100.0%
Q2 2021$5,033,000
+5.5%
1,236,595
+16.9%
0.01%0.0%
Q1 2021$4,770,000
+846.4%
1,057,663
+933.4%
0.01%
+500.0%
Q4 2020$504,000
+30.6%
102,349
+57.2%
0.00%
Q3 2020$386,000
+38.4%
65,095
-38.0%
0.00%
Q2 2020$279,000
-63.1%
105,000
-72.9%
0.00%
-100.0%
Q1 2020$756,000
+236.0%
387,516
+1867.1%
0.00%
Q2 2019$225,00019,7000.00%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 3,661,237$14,901,0000.56%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,553,398$26,672,0000.47%
Alpine Global Management, LLC 354,524$1,443,0000.20%
DELTEC ASSET MANAGEMENT LLC 275,500$1,121,0000.15%
Kamunting Street Capital Management, L.P. 67,594$275,0000.11%
IHT Wealth Management, LLC 340,147$1,384,0000.09%
Redmile Group, LLC 1,358,825$5,530,0000.08%
GSA CAPITAL PARTNERS LLP 173,318$705,0000.08%
ArrowMark Colorado Holdings LLC 1,815,091$7,387,0000.06%
GPS Wealth Strategies Group, LLC 49,025$200,0000.05%
View complete list of XERIS PHARMACEUTICALS INC shareholders